924 related articles for article (PubMed ID: 15019750)
1. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and therapeutic applications of iontophoresis.
Sieg A; Wascotte V
J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
4. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
Gratieri T; Kalia YN
Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
[TBL] [Abstract][Full Text] [Related]
5. Transdermal iontophoretic drug delivery: advances and challenges.
Ita K
J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
[TBL] [Abstract][Full Text] [Related]
6. Transdermal drug delivery.
Guy RH
Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
[TBL] [Abstract][Full Text] [Related]
7. Iontophoretic drug delivery system: a review.
Semalty A; Semalty M; Singh R; Saraf SK; Saraf S
Technol Health Care; 2007; 15(4):237-45. PubMed ID: 17673833
[TBL] [Abstract][Full Text] [Related]
8. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
[TBL] [Abstract][Full Text] [Related]
9. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.
Wang Y; Thakur R; Fan Q; Michniak B
Eur J Pharm Biopharm; 2005 Jul; 60(2):179-91. PubMed ID: 15939232
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis.
Kajimoto K; Yamamoto M; Watanabe M; Kigasawa K; Kanamura K; Harashima H; Kogure K
Int J Pharm; 2011 Jan; 403(1-2):57-65. PubMed ID: 20970487
[TBL] [Abstract][Full Text] [Related]
11. Low-frequency sonophoresis: a review.
Mitragotri S; Kost J
Adv Drug Deliv Rev; 2004 Mar; 56(5):589-601. PubMed ID: 15019748
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in transdermal drug delivery.
Subedi RK; Oh SY; Chun MK; Choi HK
Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
[TBL] [Abstract][Full Text] [Related]
13. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.
Wang Y; Zeng L; Song W; Liu J
Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687
[TBL] [Abstract][Full Text] [Related]
14. Iontophoretic drug delivery using the IOMED Phoresor system.
Fischer GA
Expert Opin Drug Deliv; 2005 Mar; 2(2):391-403. PubMed ID: 16296762
[TBL] [Abstract][Full Text] [Related]
15. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
[TBL] [Abstract][Full Text] [Related]
16. Vesicles as tools for the modulation of skin permeability.
Dubey V; Mishra D; Nahar M; Jain NK
Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
[TBL] [Abstract][Full Text] [Related]
17. Skin electroporation for transdermal and topical delivery.
Denet AR; Vanbever R; Préat V
Adv Drug Deliv Rev; 2004 Mar; 56(5):659-74. PubMed ID: 15019751
[TBL] [Abstract][Full Text] [Related]
18. AC electrokinetic platform for iontophoretic transdermal drug delivery.
Lvovich VF; Matthews E; Riga AT; Kaza L
J Control Release; 2010 Jul; 145(2):134-40. PubMed ID: 20420867
[TBL] [Abstract][Full Text] [Related]
19. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
20. Transdermal drug delivery systems: skin perturbation devices.
Brown MB; Traynor MJ; Martin GP; Akomeah FK
Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]